$QBTS

Ghai Rohit sold $357K of QBTS

Ghai Rohit sold 13,518 shares of D-Wave Quantum Inc. (QBTS) at $26.41 ($0.36M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ghai Rohit
Published Jun 16, 2026, 9:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QBTS
Neutral
high confidence
Mentioned
$QBTS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QBTSNeutralLow
01

Why it matters

The disclosure updates the insider’s ownership level but does not introduce new fundamentals (no earnings, guidance, deal, or regulatory action). Traders may still monitor for patterns of insider activity beyond this single sale.

02

Market read

A routine 10b5-1 insider sale for ~$357K; likely limited incremental trading catalyst.

03

What to watch

The article provides only the sale size and that it was pre-arranged; it does not indicate whether other insiders bought, whether the plan is part of scheduled diversification, or whether the stock price moved materially around the sale date.

Relevance 3/10Novelty 5/10Timing: Filed on 2026-06-16; sale executed 2026-06-15.

Background

This is an SEC Form 4 insider transaction disclosure for a director of D-Wave Quantum, including trade size, price, and post-transaction holdings.

Company-level read

Ticker impact

$QBTSNeutralHigh confidence
Context

D-Wave Quantum director Ghai Rohit sold 13,518 shares in an open-market transaction for about $357K under a 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is a Form 4 insider sale explicitly tied to a pre-arranged 10b5-1 plan, which usually reduces interpretive weight versus discretionary selling.

Market effects

Minimal—this is company-specific insider activity with no sector-wide regulatory/product signal.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read by some traders as a mild negative read-through on near-term expectations.

Key entities

  • D-Wave Quantum Inc.

    Company whose director insider sale is disclosed on SEC Form 4.

  • Ghai Rohit

    Director who sold 13,518 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QBTSMed

Why D-Wave Quantum (QBTS) Stock Is Up Today

D-Wave Quantum (QBTS) shares rose 4.0% today, potentially driven by a new partnership with CGI to expand commercial adoption and a $100M U.S. government funding agreement. The partnership integrates D-Wave's quantum platforms into CGI's services, targeting sectors like logistics and energy. Analysts have set a median price target of $40.0 for QBTS.

$IONQMed

Quantum Stocks Catch a Bid After IonQ Shows Real-Time Error Correction - IonQ (NYSE:IONQ), D-Wave Quantum

IonQ (NYSE:IONQ) announced a real-time quantum error-correction decoder, causing its stock to rise 11.93% premarket. The company claims its technology handles up to 408 logical qubits with minimal delay. Other quantum stocks, including D-Wave (NYSE:QBTS) and Rigetti (NASDAQ:RGTI), also gained. IonQ's stock is still 46% below its 52-week high of $84.64.

$QBTSMedAI 8/10

D-Wave Quantum Just Got $100 Million From the U.S. Government. It's Also Burning Through Roughly $37 Million a Quarter. With Its Stock Down 60% From the Peak, Is It a Bargain or a Trap?

D-Wave Quantum (QBTS) shares fell 60% from their 52-week high. The company reported a 1,120% year-over-year increase in bookings to $35.5 million, but revenue remained flat at $3.1 million. It received $100 million in U.S. government funding for R&D. Analysts are bullish, with an average price target of $35. However, the company has a high cash burn rate of $37 million per quarter and trades at a high valuation.